Recent Updates
Recently added Catalysts
CHRS Positive Sentiment

Coherus BioSciences to Participate at Upcoming November Investor Conferences

Friday, November 3, 2023 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Coherus BioSciences, Inc. (Nasdaq: CHRS) has announced its participation in several investor conferences throughout November 2023. The company will engage in one-on-one meetings at the Truist Securities BioPharma Symposium in New York City on November 8. Additionally, Coherus will present a fireside chat at the UBS Biopharma Conference in Miami on November 9, as well as at the Evercore ISI HealthCONx Conference held from November 28-30 in Miami. Webcasts of these presentations will be made available on their investor relations page.
Price reaction · baseline $3.32 (2023-11-02 close) · hit after-hours · 1 other CHRS headline(s) in the window, move may be shared
day 0 close
+8.7%
day 1
+6.6%
day 3 · peak
-38.9%

Market Sentiment Analysis

POSITIVE FACTORS

  • Coherus is actively engaging with investors, indicating strong company positioning.
  • Participation in multiple high-profile conferences suggests confidence in their strategies.
  • The availability of webcasts enhances accessibility for investors.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+136%
120-day peak, hindsight
Typical move
6.6%
average across 12 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
CHS-0214
Phase 3 · Rheumatoid Arthritis

Full Press Release Details

REDWOOD CITY, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus“, Nasdaq: CHRS) today announced that senior management will participate in the following investor conferences:
Truist Securities BioPharma Symposium In New York City on Wednesday, November 8, 2023, for 1x1 meetings only.
UBS Biopharma Conference in Miami on Thursday, November 9, 2023, a fireside chat presentation at 11:30 a.m. Eastern Time will be webcast.
6th Annual Evercore ISI HealthCONx Conference in Miami on November 28-30, 2023, a fireside chat presentation on November 30th at 12:30 p.m. Eastern Time will be webcast.
A live audio webcast and an archive of the presentations from UBS Biopharma and Evercore ISI HealthCONx conferences will be available on the investors’ page of the Coherus website at http://investors.coherus.com.
Coherus Contact Information:

Frequently Asked Questions

When is Coherus participating in the Truist Securities BioPharma Symposium?

Coherus will participate in the Truist Securities BioPharma Symposium on November 8, 2023.

What event is Coherus attending on November 9, 2023?

Coherus will have a fireside chat presentation at the UBS Biopharma Conference.

When will Coherus present at the Evercore ISI HealthCONx Conference?

Coherus will present on November 30, 2023, during the Evercore ISI HealthCONx Conference.

Where can I find the webcast of Coherus's presentations?

Webcasts of the presentations will be available on Coherus's investors' page.

Who is the contact for Coherus investor relations?

The contact for Coherus investor relations is the VP of Investor Relations.

ShareAdd on Google
Tags: CHRS Viatris Investor Conferences Healthcare Coherus BioSciences investor conferences biopharma symposium UBS Biopharma Conference
Last updated: Nov 3, 2023

Biotech snapshot

Cash runway
$105M liquidity · $21M/mo burn
~5 mo
High dilution risk
Lead asset
CHS-0214Phase 3
Rheumatoid Arthritis →

Catalyst track record

+136%
best trade around CHRS's most recent catalyst

Peak hindsight return over a 120-day window, across 12 tracked FDA/PDUFA catalysts for CHRS.

See every catalyst's timing & PoA →